Profile
Graeme Fraser is currently the Chief Scientific Officer at Ogeda SA. Previously, he worked as a Principal at AstraZeneca Canada, Inc. and Viron Therapeutics, Inc. He also served as the Vice President-Drug Discovery at Tranzyme Pharma, Inc. (Canada).
Dr. Fraser holds a doctorate degree from McGill University.
Graeme Fraser active positions
| Companies | Position | Start |
|---|---|---|
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Chief Tech/Sci/R&D Officer | - |
Former positions of Graeme Fraser
| Companies | Position | End |
|---|---|---|
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for inflammatory disorders | Corporate Officer/Principal | - |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | Corporate Officer/Principal | - |
Tranzyme Pharma, Inc. (Canada) | Corporate Officer/Principal | - |
Training of Graeme Fraser
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | Health Technology |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for inflammatory disorders | Health Technology |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
Tranzyme Pharma, Inc. (Canada) |
- Stock Market
- Insiders
- Graeme Fraser
















